Analysis of immune system and inflammatory molecules in cardiac disease.
Not Applicable
Recruiting
- Conditions
- Cardiac disease (acute coronary syndrome, angina pectoris, valvular disease, heart failure, arrhythmia, and so on)
- Registration Number
- JPRN-UMIN000012049
- Lead Sponsor
- Department of cardiology Kobe University School of medicine
- Brief Summary
We reported 3 papers about inflammation and cardiovascular diseases 1) Regulatory/Effector T-cell ratio is reduced in coronary artery disease. (Circ J. 2014 Nov 25;78(12):2935-41) 2) Circulating intermediate CD14++CD16+monocytes are increased in patients with atrial fibrillation and reflect the functional remodelling of the left atrium.(Suzuki A et al Europace.2016.in press) 3) Analysis of gut microbiota in coronary artery disease patients: a possible link between gut microbiota and coronary artery disease. (Takuo E et al. Journal of Athersclerosis and Thrombosis 2016 in press)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who do not agree to this study and those who are not appropriate for this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The discrepancy of immune system, inflammatory molecules, and gut microbiota between cardiac disease patients and healthy volunteers.
- Secondary Outcome Measures
Name Time Method